article thumbnail

Biotts claims a first with insulin delivery across skin

pharmaphorum

Polish drug delivery company Biotts says it has demonstrated delivery of insulin across the skin for the first time without the use of an injection system.

Insulin 115
article thumbnail

Oramed inks deal to commercialize oral insulin in South Korea

BioPharma Reporter

Oramed Pharmaceuticals, a company focused on the development of oral drug delivery platforms, has signed an exclusive commercial distribution agreement for the Republic of Korea with local player, Medicox Co Ltd, in relation to its oral insulin candidate.

Insulin 95
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novo Nordisk once-weekly insulin clears first phase 3 test

pharmaphorum

For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that. cases of hypoglycaemia per year with insulin icodec, versus 0.27 events for the once-daily drug. In absolute terms, there were 0.73

Insulin 98
article thumbnail

Droplet Micron Insulin Needle Offers Innovation in Crowded Diabetes Supply Market

XTalks

Being hailed as the world’s shortest and thinnest needle for insulin injection, Droplet Micron has recently been introduced into the pen needle market by HTL (High Tech Lab)-STREFA, Inc. These are important feature innovations for those that depend on insulin injections. The new and innovative needle measures at just 34G x 3.5mm.

Insulin 98
article thumbnail

New Amazon Pharmacy TV Commercials Emphasize Hassle-Free Drug Delivery

XTalks

Amazon Pharmacy launched a pair of TV spots last month to showcase the ease of its drug delivery service for consumers. In 2023, it introduced RxPass , a prescription drug program that offers common drugs for a flat fee of $5. According to Statista , the global online pharmacy market is predicted to hit $82.42

article thumbnail

In the News: September Regulatory and Development Updates

Camargo

Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device. The FDA has announced its approval of a bluetooth-controlled insulin delivery and monitoring system for use in pediatric patients ages 2 through 6 with Type 1 diabetes.

article thumbnail

Medtronic’s MiniMed Insulin Pumps Get Class I FDA Recall

XTalks

The US Food and Drug Administration (FDA) has issued a Class I label for the recall of Medtronic’s MiniMed insulin pumps. The devices are used to regulate blood glucose levels by delivering precise amounts of insulin based on readings from an integrated continuous glucose monitor (CGM).

Insulin 52